Torrent Pharmaceuticals Limited — Important, 03-04-2025: Disclosure under Regulation 6(1)

The company has announced a board meeting on a forthcoming date to discuss and approve the financial results for the quarter and half-year. This meeting may reveal key insights into operational performance and financial health, potentially influencing investor sentiment. Depending on the outcomes, shareholders could see implications for future growth strategies or adjustments in management focus. This update suggests a positive outlook as investors seek clarity on financial results that could bolster confidence in the company's direction and performance.